Business Context and Reporting Period
Company: Braskem S.A.
Filing Type: Form 6-K (Earnings Release)
Reporting Period: Second Quarter 2025 (Ended June 30, 2025)
Business Overview: Braskem is the largest resin producer in the Americas and a global leader in biopolymers. The company operates across Brazil/South America, the United States/Europe, and Mexico segments.
Key Financial Metrics
- Recurring EBITDA: US$74 million (R$427 million) for 2Q25.
- Net Income (Loss): Net loss attributable to shareholders of US$45 million (R$267 million) for 2Q25. For the first half of 2025, net profit was R$431 million.
- Cash Flow: Total cash consumption of R$1.4 billion (US$256 million) in 2Q25. Operational cash consumption was R$175 million.
- Debt: Corporate gross debt of approximately US$8.5 billion. Adjusted net debt was US$6.8 billion.
- Liquidity: Cash position of US$1.7 billion (excluding Braskem Idesa), plus a US$1.0 billion revolving credit facility available until December 2026.
- Debt Maturity: Average term of 9 years; 68% of maturities begin in 2030.
Material Changes vs. Prior Periods
Consolidated Recurring EBITDA of US$74 million was lower than both 1Q25 and 2Q24. The decline was driven by reduced international spreads for Polyethylene (PE) and Polyvinyl Chloride (PVC), scheduled maintenance shutdowns in Mexico, and an inventory mismatch where feedstock costs from previous higher-price periods impacted current profitability.
- Brazil/South America: Recurring EBITDA was US$152 million. Resin sales in Brazil grew 3% and exports grew 19% compared to 1Q25, despite a 10% drop in international PE reference prices.
- United States and Europe: Recorded negative Recurring EBITDA of US$8 million due to higher feedstock costs from prior periods, despite higher sales volumes.
- Mexico: Recorded negative Recurring EBITDA of US$9 million. Performance was impacted by a general maintenance shutdown at Braskem Idesa and lower ethane supply from Pemex.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Strategy
Management is executing a "Resilience and Transformation Program" focused on maximizing EBITDA and cash generation. Key strategic pillars include optimizing naphtha-based assets, expanding gas-based capacity (e.g., Transforma Rio project), and migrating to renewables (targeting 1 million tons of bioproducts by 2030).
Material Risks and Contingencies
- Alagoas Geological Event: A significant contingency remains regarding the geological event in Maceió, Alagoas. The provision balance was R$4.67 billion at the end of 2Q25, a decrease of 8% from 1Q25 due to present value adjustments and payments. The company notes that future costs may differ significantly from estimates.
- Credit Ratings: In May 2025, Fitch downgraded Braskem's global scale rating to 'BB' (Stable), and S&P downgraded it to 'BB' (Negative). National scale ratings remain 'AAA(bra)' (Fitch) and 'brAAA' (S&P).
- Market Conditions: Global demand is impacted by trade tensions between the US and China and tariff uncertainties, leading to reduced price references for resins and main chemicals.
Investor Verification Checklist
- Alagoas Provision Accuracy: Verify the sufficiency of the R$4.67 billion provision against potential future legal claims and geological stabilization costs.
- Feedstock Cost Lag: Assess the duration of the inventory mismatch between high-cost feedstock and current lower sales prices.
- Mexico Operations: Monitor the impact of Pemex ethane supply reliability and the completion of the Braskem Idesa maintenance shutdown on future volumes.
- Cash Burn Rate: Review the sustainability of the R$1.4 billion quarterly cash consumption against the US$1.7 billion cash balance and debt maturity profile.
- Regulatory Support: Track the legislative progress of the "PRESIQ" bill in Brazil, which is critical for maintaining the competitiveness of the local chemical industry.